Skip to main content

Neonatal candidiasis: prophylaxis and treatment.

Publication ,  Journal Article
Tiffany, KF; Smith, PB; Benjamin, DK
Published in: Expert Opin Pharmacother
August 2005

The incidence of candidiasis has risen in neonatal intensive care units as advances in medical therapy have allowed for increased survival of extremely preterm neonates. The mortality of candidiasis has been reported to be 20% by several multi-centre studies. Definitive guidance for prophylaxis and treatment is hindered by lack of large, multi-centre, randomised controlled trials. Systemic prophylaxis is currently not recommended for any neonatal population, and amphotericin B deoxycholate continues to be used as first-line therapy for the treatment of invasive disease.

Duke Scholars

Published In

Expert Opin Pharmacother

DOI

EISSN

1744-7666

Publication Date

August 2005

Volume

6

Issue

10

Start / End Page

1647 / 1655

Location

England

Related Subject Headings

  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Pharmacology & Pharmacy
  • Infant, Newborn
  • Infant, Low Birth Weight
  • Humans
  • Fluconazole
  • Drug Combinations
  • Deoxycholic Acid
  • Candidiasis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tiffany, K. F., Smith, P. B., & Benjamin, D. K. (2005). Neonatal candidiasis: prophylaxis and treatment. Expert Opin Pharmacother, 6(10), 1647–1655. https://doi.org/10.1517/14656566.6.10.1647
Tiffany, Kenneth F., Phillip B. Smith, and Daniel K. Benjamin. “Neonatal candidiasis: prophylaxis and treatment.Expert Opin Pharmacother 6, no. 10 (August 2005): 1647–55. https://doi.org/10.1517/14656566.6.10.1647.
Tiffany KF, Smith PB, Benjamin DK. Neonatal candidiasis: prophylaxis and treatment. Expert Opin Pharmacother. 2005 Aug;6(10):1647–55.
Tiffany, Kenneth F., et al. “Neonatal candidiasis: prophylaxis and treatment.Expert Opin Pharmacother, vol. 6, no. 10, Aug. 2005, pp. 1647–55. Pubmed, doi:10.1517/14656566.6.10.1647.
Tiffany KF, Smith PB, Benjamin DK. Neonatal candidiasis: prophylaxis and treatment. Expert Opin Pharmacother. 2005 Aug;6(10):1647–1655.

Published In

Expert Opin Pharmacother

DOI

EISSN

1744-7666

Publication Date

August 2005

Volume

6

Issue

10

Start / End Page

1647 / 1655

Location

England

Related Subject Headings

  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Pharmacology & Pharmacy
  • Infant, Newborn
  • Infant, Low Birth Weight
  • Humans
  • Fluconazole
  • Drug Combinations
  • Deoxycholic Acid
  • Candidiasis